Title : Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Pub. Date : 2019 May 9

PMID : 30814061






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We found that ibrutinib decreases the CLL PFs and, interestingly, also reduces AID expression, which correlates with dampened AKT and Janus Kinase 1 signaling. ibrutinib AKT serine/threonine kinase 1 Homo sapiens